A Novel Prognostic Model Based on the Serum Iron Level for Patients With Early-Stage Triple-Negative Breast Cancer

por Hua, Xin, Duan, Fangfang, Huang, Jiajia, Bi, Xiwen, Xia, Wen, Song, Chenge, Wang, Li, Jiang, Chang, Yuan, Zhongyu
Publicado 2021

Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer

por Duan, Fangfang, Li, Jianpei, Huang, Jiajia, Hua, Xin, Song, Chenge, Wang, Li, Bi, Xiwen, Xia, Wen, Yuan, Zhongyu
Publicado 2021

A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Early-Stage Breast Cancer

por Hua, Xin, Duan, Fangfang, Zhai, Wenyu, Song, Chenge, Jiang, Chang, Wang, Li, Huang, Jiajia, Lin, Huanxin, Yuan, Zhongyu
Publicado 2022

An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Breast Cancer

por Yuan, Jing, Duan, Fangfang, Zhai, Wenyu, Song, Chenge, Wang, Li, Xia, Wen, Hua, Xin, Yuan, Zhongyu, Bi, Xiwen, Huang, Jiajia
Publicado 2021

Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus

por Duan, Fangfang, Song, Chenge, Ma, Yuyu, Jiang, Kuikui, Xu, Fei, Bi, Xiwen, Huang, Jiajia, Hong, Ruoxi, Huang, Zhangzan, Lu, Qianyi, Yuan, Zhongyu, Wang, Shusen, Xia, Wen
Publicado 2021

Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study

por Ma, Yuyu, Duan, Fangfang, Zhuang, Yue, Song, Chenge, Huang, Jiajia, Xia, Wen, Hong, Ruoxi, Zheng, Qiufan, Wang, Shusen, Shi, Yanxia, Xu, Fei, Yuan, Zhongyu, Bi, Xiwen
Publicado 2022

High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study

por Su, Yanhong, Zhang, Yarui, Hua, Xin, Huang, Jiajia, Bi, Xiwen, Xia, Wen, Wang, Xinyue, Huang, Zhangzan, Song, Chenge, Zhong, Yongyi, Shi, Yanxia, Wang, Shusen, Fan, Wei, Yuan, Zhongyu
Publicado 2021

The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: a phase II, multicenter,...

por Duan, Fangfang, Zhong, Muyi, Ma, Yuyu, Song, Chenge, Zhang, Lehong, Lin, Ying, Wu, Zhiyong, Zhang, Yuanqi, Huang, Jiajia, Xu, Fei, Shi, Yanxia, Wang, Shusen, Yuan, Zhongyu, Xia, Wen, Bi, Xiwen
Publicado 2022